Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Equity: 2019-2025

Historic Return on Equity for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to -0.29%.

  • Arcturus Therapeutics Holdings' Return on Equity fell 5.00% to -0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.29%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.31% for FY2024, which is 20.00% down from last year.
  • As of Q3 2025, Arcturus Therapeutics Holdings' Return on Equity stood at -0.29%, which was down 13.12% from -0.26% recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' 5-year Return on Equity high stood at 0.38% for Q1 2023, and its period low was -0.95% during Q1 2022.
  • Its 3-year average for Return on Equity is -0.11%, with a median of -0.26% in 2025.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Return on Equity soared by 133bps in 2023 and then plummeted by 77bps in 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Return on Equity (Quarterly) stood at -0.83% in 2021, then surged by 88bps to 0.05% in 2022, then dropped by 16bps to -0.11% in 2023, then decreased by 22bps to -0.32% in 2024, then dropped by 5bps to -0.29% in 2025.
  • Its Return on Equity stands at -0.29% for Q3 2025, versus -0.26% for Q2 2025 and -0.29% for Q1 2025.